Commitments and Contingent Liabilities - Additional Information (Details) - USD ($) $ in Millions |
6 Months Ended | |
|---|---|---|
Jul. 02, 2026 |
Jun. 30, 2026 |
|
| Lessee, Lease, Description [Line Items] | ||
| Operating lease, description | As of June 30, 2026, the Company leased office and laboratory space in Emeryville, California under operating leases (the “Emeryville Lease”). On February 27, 2026, the Company entered into a lease amendment to reduce total office and lab space and add new office space in the same building, which commenced on July 2, 2026. The term of the Emeryville Lease is through August 31, 2030. Base rent payments under the lease amendment are approximately $0.2 million per month. In addition to the base rent, which includes escalating payments over the lease term, the Company pays variable costs related to operating expenses and taxes, which are recognized as incurred. | |
| Undiscounted lease obligations, operating lease | $ 10.5 | |
| Undiscounted lease obligations, finance lease | $ 0.1 | |
| Subsequent Event [Member] | ||
| Lessee, Lease, Description [Line Items] | ||
| Operating lease expiration date | Aug. 31, 2030 | |
| Base rent payments per month | $ 0.2 | |
| Laboratory Equipment | ||
| Lessee, Lease, Description [Line Items] | ||
| Finance lease term of contract | 36 months |